- Trials with a EudraCT protocol (181)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
181 result(s) found for: Patient education.
Displaying page 1 of 10.
EudraCT Number: 2018-003490-10 | Sponsor Protocol Number: GETAID-2018-01 | Start Date*: 2019-09-30 | |||||||||||
Sponsor Name:GETAID | |||||||||||||
Full Title: An open-label randomized trial COmparing staNdard of care versus Treat to target with telemonitoRing and patient education in patients with ulcerative cOlitis initiating adalimumab : The CONTROL tr... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004077-32 | Sponsor Protocol Number: BCRU/11/Ibu-AOM/001 | Start Date*: 2015-12-29 |
Sponsor Name:Berlin-Chemie AG | ||
Full Title: A randomized open-label, multinational, multicentre, phase III clinical study to evaluate the efficacy and safety of Ibuprofen oral suspension 20 mg/ml and Ibuprofen oral suspension 40 mg/ml (Berli... | ||
Medical condition: Acute otitis media (AOM) is an acute inflammatory disease involving the mucosa of the middle ear. AOM is one of the most frequent complications of upper respiratory tract infections in children. T... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-004671-12 | Sponsor Protocol Number: s55892 | Start Date*: 2014-06-20 |
Sponsor Name:University of Leuven | ||
Full Title: Predictive value of biomarkers in patients with amnestic mild cognitive impairment | ||
Medical condition: Mild cognitive impairment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000788-30 | Sponsor Protocol Number: 1.2022 | Start Date*: 2023-04-13 |
Sponsor Name:Uzdrowisko Kamień Pomorski S.A. | ||
Full Title: Evaluation of the effectiveness of Methocarbamol in the treatment of spasticity in people with spinal cord injury. | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000055-41 | Sponsor Protocol Number: CV185-220 | Start Date*: 2013-08-09 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Assessment of an Education and Guidance programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN) | |||||||||||||
Medical condition: Patients with Non-Valvular Atrial Fibrillation with at least one risk factor for stroke and indicated for oral anticoagulant. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) GB (Completed) ES (Completed) DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001468-21 | Sponsor Protocol Number: KIIOIW001 | Start Date*: 2006-08-24 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Sympthomatic and prophylactic treatment of drug induced oral dryness in elderly patients with high drug consumption. | ||
Medical condition: Oral dryness is a common problem with serious consquences, especially among elderly individuals. The most common reason for oral dryness is drug consumption. Research has shown that an individual w... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000809-71 | Sponsor Protocol Number: APPI2-PT-2019-01 | Start Date*: 2019-06-18 | |||||||||||
Sponsor Name:The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark | |||||||||||||
Full Title: Direct comparison of intra-articular saline injections with an education plus exercise program for treatment of knee osteoarthritis symptoms: A randomised, open label, controlled, evidence based trial | |||||||||||||
Medical condition: Knee osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002780-30 | Sponsor Protocol Number: 9515 | Start Date*: 2022-12-01 | |||||||||||
Sponsor Name:Aarhus University Hospital, The Research Clinic for Functional Disorders and Psychosomatics | |||||||||||||
Full Title: Efficacy of patient education and duloxetine, alone and in combination, for patients with multiorgan bodily distress syndrome: a partial-factorial randomized controlled trial (the EDULOX-trial) | |||||||||||||
Medical condition: Multiorgan Functional somatic disorders (FSD) / bodily disstress syndrome (BDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002509-39 | Sponsor Protocol Number: RD.03.SPR.102710 | Start Date*: 2014-10-30 | |||||||||||
Sponsor Name:GALDERMA R&D | |||||||||||||
Full Title: Effect of Patient Education on Treatment Adherence and Satisfaction among Acne Patients Receiving Once-Daily EpiduoTM Gel Treatment in Primary Care Clinics | |||||||||||||
Medical condition: Acne vulgaris | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005544-79 | Sponsor Protocol Number: Beau_Resp_05_001 | Start Date*: 2006-03-24 |
Sponsor Name:The Clinical Research Centre, RCSI Education and Research Centre | ||
Full Title: Adalimumab (Humira) as add-on therapy in the treatment of patients with severe persistent therapy resistant asthma | ||
Medical condition: Severe Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-010067-16 | Sponsor Protocol Number: CN156018 | Start Date*: 2009-07-08 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients with Prodromal ... | |||||||||||||
Medical condition: ALZHEIMER DISEASE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) NL (Completed) FR (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021842-23 | Sponsor Protocol Number: TT108 | Start Date*: 2010-09-15 |
Sponsor Name:University of Iceland | ||
Full Title: A randomized clinical trial of the effects of Tea tree essential oil on adult leg cellulitis of class II in the Eron/Dall classification system for cellulitis: Pilot study. | ||
Medical condition: Cellulitis of the lower leg of adult patients that have been admitted to Landspitali University Hospital and are on iv antibiotics. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IS (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020737-50 | Sponsor Protocol Number: MRZ90001_2267_1 | Start Date*: 2010-11-10 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of 10mg memantine in the treatment of memory, concentration or attention problems... | |||||||||||||
Medical condition: Subjective memory, concentration or attention problems (subjective cognitive impairment) in the absence of dementia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004527-32 | Sponsor Protocol Number: SITADS | Start Date*: 2016-11-22 | ||||||||||||||||
Sponsor Name:King's College London [...] | ||||||||||||||||||
Full Title: Pilot randomised controlled trial of SITAgliptin for Depressive Symptoms in type 2 diabetes | ||||||||||||||||||
Medical condition: Depression in type 2 diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019726-14 | Sponsor Protocol Number: CRO-2010-01 | Start Date*: 2010-09-20 | |||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO | |||||||||||||
Full Title: SORAFENIB IN ELDERLY PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (SERCC STIDY). IMPACT OF ADVERSE EVENTS MANAGEMENT IN ELDERLY mRCC PATIENTS TREATED WITH SORAFENIB. | |||||||||||||
Medical condition: PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AGED >/= 65 YRS | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006005-30 | Sponsor Protocol Number: APG101_CD_018 | Start Date*: 2022-09-22 | |||||||||||
Sponsor Name:Apogenix AG | |||||||||||||
Full Title: A Multicenter, Randomized, Placebo-controlled, Double-blind, Phase III Trial to Evaluate the Efficacy of Asunercept for the Treatment of Hospitalized Patients with Moderate to Severe COVID-19 Disease | |||||||||||||
Medical condition: Moderate to Severe COVID-19 Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Completed) AT (Prematurely Ended) FR (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001995-20 | Sponsor Protocol Number: 2205p | Start Date*: 2011-03-14 |
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | ||
Full Title: A pilot study on educational aproach to improve compliance to medical precriptions in transplantation recipients. | ||
Medical condition: Patients who underwent liver or renal transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020303-69 | Sponsor Protocol Number: 2010Axcan9682 | Start Date*: 2011-09-19 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Enzyme substitution in exocrine pancreatic insufficiency; Self administration against a fixed dose regimen. | |||||||||||||
Medical condition: Exocrine pancreatic insufficiency in patients with chronic pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001270-28 | Sponsor Protocol Number: Protokół_ASAPOL_wersja4_z_dnia_27_0 | Start Date*: 2012-09-21 |
Sponsor Name:Medical Centre of Postgraduate Education, Poland | ||
Full Title: The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Continuing or Discontinuing on Aspirin: a Multicenter, Double-blind, Placebo-controlled, Randomized Clinical Trial | ||
Medical condition: Bleeding after removal large colorectal polyps in patients taking aspirin in profilactic doses or placebo | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001331-26 | Sponsor Protocol Number: PROLIFIC2020 | Start Date*: 2020-04-14 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: ChemoPROphyLaxIs For covId-19 infeCtious disease (the PROLIFIC trial) | |||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19) caused by the infection, SARS-CoV-2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
